Sunrest Lifescience P/E Ratio

Current P/E Ratio
2.0
Low Valuation
Very Low - Potentially undervalued or facing challenges

Sunrest Lifescience P/E ratio. Sunrest Lifescience (SUNREST) P/E ratio is 2.0 (Low), EPS (TTM) ₹9.59, current price ₹ on None — Very Low - Potentially undervalued or facing challenges. Check SUNREST market cap trends to track the company's total market size over time.

Current Valuation Metrics

P/E Ratio 2.0
Current Price ₹
EPS (TTM) ₹9.59
Exchange None

Valuation Signal

Signal Undervalued

Sector Context

Sector Average 52.39
Sector Median 29.6
Sector Rank #1 of 255
Sector Percentile 0.4%

SUNREST P/E Ratio — Valuation Signal & Historical Context

Sunrest Lifescience P/E 2.0 — signal: Undervalued. For live price, revenue and the complete fundamental profile, see SUNREST share price screener.

  • Stock appears undervalued with PE of 2.0, suggesting potential buying opportunity
  • Trading at discount to sector average PE of 52.39

SUNREST vs Healthcare Peers — P/E Ratio Comparison

Sunrest Lifescience P/E 2.0 vs Healthcare average 52.39, median 29.6 — range 2.6–733.0.

Sector Average
52.39
Sector Median
29.6
Lowest P/E
2.6
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low
Colinz Laboratories COLINZ 6.5 ₹17 Low